Point-of-care testing companies develop and manufacture diagnostic tests designed for use at or near the patient, rather than relying on conventional central laboratories. These technologies support timely clinical decisions in hospitals, GP surgeries, pharmacies, ambulances, community care and some home-testing settings.
This category includes companies working on:
Browse 40 UK point-of-care testing companies below.
Decentralised molecular and multiomic diagnostics as a service
Molomix Bioscience is a Welsh biotechnology company providing decentralised molecular and multiomic diagnostics for research, clinical and applied testing settings. The company offers subscription-based access to sequencing and molecular diagnostic platforms, supported by consumables, training and technical support.…
High-sensitivity lateral flow diagnostics for point-of-care testing
SwiftDx is a Cambridge-based diagnostics company developing a next generation of high-sensitivity lateral flow assays using proprietary eAMP (enhanced Amplification) and DNA detection technologies. Its platform enables detection of targets undetectable by conventional lateral flow tests, without requiring specialist…
Electrochemical lateral flow diagnostics for accessible at-home health testing
éclateral is a UK-based developer of electrochemical lateral flow diagnostic technology for at-home and point-of-care testing. The company's portable reader pairs with adapted lateral flow test cassettes and a companion mobile app to deliver quantitative, sensitive results beyond standard optical lateral flow…
AI-powered portable diagnostics platform for field-based disease testing
Vidiia is a diagnostics company developing AI-powered, portable molecular testing devices for point-of-care and field-based disease detection. Its platform combines RT-LAMP assay chemistry with smartphone-connected artificial intelligence to interpret results, and has received UK regulatory approval for medical use.…
In vitro diagnostic reagents, test kits and analysers for clinical laboratories
Fortress Diagnostics is a Northern Ireland-based manufacturer of in vitro diagnostic products, supplying clinical chemistry reagents, immunoassays, haematology reagents, haemostasis consumables, serology test kits, quality controls and calibrators, and diagnostic instrumentation to hospitals, blood banks, and research…
Single-molecule counting point-of-care diagnostics for cardiac and other biomarkers
Psyros Diagnostics develops a point-of-care diagnostic system using single-molecule counting technology to measure biomarkers at extremely low concentrations within around ten minutes, from a single drop of blood. The platform's lead application is a high-sensitivity troponin assay for cardiac diagnosis, with the…
Diagnostic reagents, instruments and quality controls for clinical and research laboratories
Randox Laboratories is a global manufacturer of in vitro diagnostic reagents, clinical chemistry analysers, quality control materials, and biochip array technology for laboratory medicine. Products serve clinical, research, molecular, forensic toxicology, food safety, and veterinary laboratory markets across more than…
GC-IMS analytical instruments for clinical, food and environmental testing
Imspex Diagnostics is a Welsh analytical instruments company developing and distributing Gas Chromatography-Ion Mobility Spectrometry platforms for clinical diagnostics, food safety and environmental analysis. Its GC-IMS technology detects target compounds and clinical biomarkers at parts-per-billion sensitivity,…
Portable multiplex PCR molecular diagnostic platform for point-of-care use
QuantuMDx is a medical technology company developing a battery-operated, handheld molecular diagnostic system that delivers multiplex PCR results from a single-use reagent cassette within 35 minutes. Designed for point-of-care and resource-limited settings, the CE-IVD marked device supports assays for respiratory…
Real-time biosensing to assess donor kidney function in transplantation
Accunea is a medical technology company developing real-time biosensing systems that monitor organ function before and after kidney transplantation. Its bedside platform uses electrochemical sensors and microfluidic cartridges to track established biomarkers of kidney function and metabolism, such as creatinine,…
Rapid blood biomarker test for pre-hospital stroke triage
Upfront Diagnostics is a diagnostic biotechnology company developing rapid blood tests for emergency stroke triage. Its lateral-flow assay measures D-dimer and glial fibrillary acidic protein (GFAP) from a finger-prick sample, providing results in under ten minutes to support identification of suspected…
Solvent-free gold nanoparticles for lateral flow and IVD diagnostics
Grove Nanomaterials is a Welsh nanotechnology company developing a sustainable, solvent-free manufacturing process for gold nanoparticles used in lateral flow assays and in-vitro diagnostics. Based on patented nanoparticle beam deposition technology developed at Swansea University, the process eliminates the chemical…
Lab-on-PCB biosensors for non-invasive point-of-care diagnostics
TeslaDiagnostiX develops miniaturised electrochemical diagnostic systems using lab-on-printed-circuit-board technology for biological sample testing. Its lead programme is a quantitative saliva glucose assay intended to provide a non-invasive alternative to blood-based measurement. The device combines disposable PCB…
Rapid molecular tests for industrial and bioprocess contamination
Fuse Diagnostics develops rapid, low-cost molecular tests for use at the point of need. Its disposable tests use proprietary amplification chemistry to detect pathogens and contaminants in under ten minutes, without requiring specialist laboratory infrastructure. The company targets applications in bioprocessing, cell…
Diagnostics, devices and diabetes care for global healthcare
Abbott Laboratories is a multinational healthcare company providing diagnostic instruments, reagents, and medical devices to hospitals, laboratories, and healthcare professionals. UK operations span commercial, R&D, and manufacturing functions across multiple sites. Core life science offerings include in vitro…
Manufacturer of lateral flow tests, ELISA kits and immunoassay reagents
Biopanda Reagents is an ISO 13485-certified manufacturer of in vitro diagnostic test kits and immunoassay reagents for clinical, veterinary, environmental, and food safety applications. The product range spans lateral flow rapid tests, ELISA kits, real-time PCR kits, and chemiluminescence assays, covering infectious…
Rapid diagnostic test kits for clinical, pharmacy and consumer markets
CIGA Healthcare is an ISO 13485-certified manufacturer of rapid lateral flow diagnostic tests and immunoassay products, supplying pharmacy outlets, health services and retailers across more than 70 countries. Its brand covers point-of-care and over-the-counter tests for pregnancy, infectious disease, cardiac…
Integrated sample collection and rapid molecular diagnostic devices
ReadyGo Diagnostics develops disposable sample-collection and preparation devices for rapid diagnostic testing. Its technology combines swab collection and lysis chemistry in a single unit and is designed to work with lateral flow, molecular and immunoassay formats. It also supports rapid isothermal molecular tests…
Point-of-care diagnostics and AI triage for cancer patients
52North is a medical technology company developing diagnostics and digital tools for urgent cancer care. Its lead programme is a point-of-care blood test designed to help chemotherapy patients assess their risk of neutropenic sepsis outside hospital, alongside an AI-supported app for triaging acute oncology symptoms.…
Clinical and laboratory diagnostics systems for the UK market
Roche Diagnostics is the UK diagnostics subsidiary of F. Hoffmann-La Roche, based in Burgess Hill, West Sussex. The company supplies high-throughput laboratory analysers, reagents, and diagnostic software to NHS hospitals, clinical laboratories, and research institutions across the UK. Its portfolio spans clinical…
This category covers developers and manufacturers of human-health diagnostic tests intended to deliver actionable results at or near the patient, including some direct-result home self-tests and investigational near-patient systems. It excludes samples merely collected at home and sent away for central laboratory analysis, research-only portable equipment without a medical diagnostic application, and veterinary-only or industrial field testing. Point-of-care refers to where a test is used, not the molecule or assay technology; an organisation can also be Molecular Diagnostics when independently supported.